Episode # 543 • 13 May 2025
Metastatic Colorectal Cancer: Discussion on the COLLISION Trial
Is minimally invasive ablation the future of metastatic cancer care? We now have the results of the COLLISION Trial, which investigates the non-inferiority of thermal ablation compared to surgical resection. How will these findings change treatment paradigms and practice patterns around metastatic colorectal cancer? In this week’s episode of BackTable, interventional radiologist Dr. Chris Beck discusses the impact and implications of the COLLISION Trial with principal investigator Dr. Martijn Meijerink from Amsterdam UMC.
Timestamps
00:00 - Introduction
03:21 - Understanding Metastatic Colorectal Cancer and IR’s Role
05:18 - Introduction to the COLLISION Trial
07:40 - Radiofrequency vs Microwave Ablation and Technological Advancements
09:02 - Trial Design and Patient Eligibility
16:20 - Ablation Techniques and Approaches
22:05 - Trial Results and Analysis
30:19 - Impact on Guidelines and Practice
39:44 - Best Practices in Thermal Ablation
43:27 - Future Directions in Interventional Oncology
Resources
You may also like
More about this episode
The doctors explore the COLLISION Trial’s design, results, complication rates, and future directions. They also cover best practices for ablation techniques and the potential for interventional oncology to enter a “golden era.” Finally, Dr. Meijerink highlights the importance of standardizing intervention quality and being present in tumor boards to ensure optimal patient care.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.